REG - Ilika plc - Nominated Adviser and Joint Broker

IlikaAnnouncement

01/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240701:nRSA3777Ua&default-theme=true

RNS Number : 3777U  Ilika plc  01 July 2024

Ilika Plc

("Ilika" or "the Company")

 

Nominated Adviser and Joint Broker

 

Ilika (AIM:IKA), an independent global expert in solid-state battery
technology, announces that, following the completion of the all-share merger
between Liberum Capital Limited and Panmure Gordon Group Limited, the Company
has changed its Nominated Adviser and Joint Broker to Panmure Liberum Limited
with immediate effect.

 

 For more information contact:

 Ilika plc                                                          www.ilika.com (http://www.ilika.com/)
 Graeme Purdy, Chief Executive                                      Via Walbrook PR
 Jason Stewart, Chief Financial Officer

 Panmure Liberum Limited (Nomad and Joint Broker)                   Tel: 020 3100 2000
 Andrew Godber, John More
 Nikhil Varghese, Joshua Borlant

 Joh. Berenberg, Gossler & Co. KG (Joint Broker)                    Tel: 020 3207 8700
 Mark Whitmore, Detlir Elezi, Natasha Ninkov

 Walbrook PR Ltd                            Tel: 020 7933 8780 / Ilika@walbrookpr.com
 Nick Rome, Charlotte Edgar, Joe Walker

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPSEUFSAELSESM